Phosphorylation, a common post-translational modification (PTM) that influences a protein’s activity, can be a deciding factor in the selection of chemotherapeutics for successful cancer treatment. Britton et al. (2014) have developed a proteomics workflow, SysQuant, that quantifies changes in pancreatic cancer phosphopeptides and their allied pathways. This information can highlight relevant drug sensitivities for onward treatment Read the rest of this article
The post Pancreatic Cancer Phosphorylome and Potential Drug Networks appeared first on Accelerating Science.